Back to Search
Start Over
U.S. FDA Approves Mylan and Biocon's Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta(r)
- Source :
- Plus Company Updates. June 5, 2018
- Publication Year :
- 2018
-
Abstract
- Netherlands: MYLAN N.V. has issued the following press release: Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.542892502